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Background
A series of patients with multiple primary melanoma
(MPM) has been studied for assessing frequency and
distribution of alterations in candidate genes involved in
susceptibility (CDKN2A) and pathogenesis (BRAF, cKIT,
CyclinD1) of such a disease.
Methods
Two hundred and twenty-seven genomic DNA samples
from paired synchronous and/or asynchronous tumour
tissues of 106 MPM patients (92 cases with two, 13 with
three, and 1 with four primary melanomas) were
screened for somatic mutations in BRAF gene and FISH-
based amplifications in cKIT and CyclynD1 genes. For
87 (84%) MPM patients from our series, peripheral blood
was available and germline DNAs was analyzed for
mutations in p16CDKN2A and p14CDKN2A genes. All
mutation analyses we performed by direct automated
DNA sequencing. Family history for melanoma was
defined according to standardized criteria.
Results
At somatic level, BRAF mutations were identified in 108/
227 (48%) primary melanoma tissues, whereas amplification
of cKIT and CyclinD1 genes was observed in 8/208 (4%)
and 28/204 (14%) analyzed tissue samples, respectively.
Considering all types of genetic events, paired samples pre-
sented a poorly consistent distribution of somatic altera-
tions in same patients [55/106 (52%) discrepant cases).
Among them, 35/106 (33%) patients presented discrepant
MPM lesions according to the BRAF mutation status.
Among the 87 MPM patients whose germline DNA was
available, 8 (9%) of them showed different CDKN2A germ-
line mutations: 7 in p16CDKN2A and 1 in p14CDKN2A.
Assessment of family history for melanoma revealed that
13/87 (15%) patients presented at least one additional
family member affected; a total of ≥ 3 melanomas in family
was observed in 20/87 (23%) cases of our series. The
CDKN2A germline mutations were found significantly
more frequent in patients with familial history of melanoma
(7/13; 54%) compared with patients without (1/74; 1.4%)
(P<0.001); analogously, CDKN2A mutations were observed
in 1/67 (1.5%) and 7/20 (35%) patients with 2 and 3 or
more melanomas in family, respectively (P<0.001).
Conclusions
The low consistency in mutation patterns at somatic level
among MPM lesions from the same patients provide
further evidence that melanomagenesis is heterogeneous
and molecularly different cell types may participate to the
development of multiple melanomas. Our findings on
germline DNA indicate that occurrence of at least 3 mela-
nomas (in patients or families) or familial recurrence of
melanoma may represent strong indicators to address
patients to CDKN2A mutation screening.
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